MediWound (MDWD) director Nachum Shamir details shares, RSUs and options
Rhea-AI Filing Summary
MediWound Ltd. director Nachum Shamir has filed a Form 3 showing his initial ownership in the company. He directly holds 49,815 ordinary shares and an additional 1,200 ordinary shares underlying restricted stock units granted on March 4, 2026, which vest in full one year after the grant date.
He also holds a series of equity derivatives over MediWound ordinary shares. These include Series A warrants over 16,336 shares at an exercise price of 13.4750 per share expiring on November 28, 2026, and several stock option grants covering 28,571, 11,800, 12,570, 9,200 and 10,000 underlying shares with exercise prices between 11.8850 and 18.5400, expiring between August 17, 2032 and March 4, 2036. The options granted on March 4, 2026 vest 100% on the one-year anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series A Warrants | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Footnotes (1)
- The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
